Kevin Zikaras

Kevin has over 14 years of experience in oncology clinical development spanning academic cancer centers, biotechnology companies, and global pharmaceutical organizations. His expertise includes clinical operations, clinical supply, data management, pharmacovigilance, quality systems, and execution of global oncology trials from early-stage development through pivotal Phase 3 studies.

Most recently, Kevin served as Vice President of Clinical Development Operations at Convergent Therapeutics. Previously, at TCR² Therapeutics, he built and led clinical operations, clinical supply, data management, and pharmacovigilance functions. Earlier, at Actinium Pharmaceuticals, he served as program lead for the pivotal Phase 3 SIERRA trial. He also managed global immuno-oncology studies at Bristol Myers Squibb and held clinical research leadership positions at Memorial Sloan Kettering Cancer Center and Columbia University Medical Center.

Kevin earned an MBA from Cornell University, an MS in Healthcare Leadership from Weill Cornell Graduate School of Medical Sciences, and an MS in Regulatory Affairs from Northeastern University.